Brief: FDA Approves First Single-Dose Generic Treatment For Influenza
17/06/2026 22:55
BRIEF-FDA Approves First Single-Dose Generic Treatment For Influenza June 17 (Reuters) - Roche Holding AG ROPC.S:
FDA APPROVES FIRST SINGLE-DOSE GENERIC TREATMENT FOR INFLUENZA
FDA: APPROVED NORWICH PHARMACEUTICALS' APPLICATION FOR GENERIC BALOXAVIR MARBOXIL TABLETS - WEBSITE
Source text: [ID:]
Further company coverage: ROPC.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roche Holding AG
See all newsTable: Swiss trade surplus at CHF 6.11 bln in May
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza